Pediatric Psychopharmacology for Primary Care. Dieser Artikel ist nicht verfügbar.Pediatric Psychopharmacology for Primary Care

Completely updated and revised, the second edition provides primary care physicians with practice-tested, condition-specific treatment recommendations for various childhood mental disorders. Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications for treatment of common psychiatric disorders and mental health or behavioral problems in children and adolescents.
 
This simple, systematic approach defines discrete levels of psychotropics and spells out group-specific roles and responsibilities in accord with AAP policies. Plus, an included digital tool offers instant access to authoritative answers on specific conditions and medications.

Includes bonus digital tool!
Get instant answers on specific conditions and medications!
 
TOPICS INCLUDE

• Conceptual framework for prescribing psychotropic drugs
• Medications for specific diagnoses: ADHD, Anxiety, and Depression
• US Food and Drug Administration-Approved antipsychotics and mood stabilizers and all other medications
• What to do when treatment is unsuccessful

Mark A. Riddle, M.D., is Professor of Psychiatry and Pediatrics and Director of the Children&;s Interventions Research Program in Psychiatry at the Johns Hopkins University School of Medicine.  The focus of Dr. Riddle&;s research, teaching and clinical practice is pediatric psychopharmacology, especially medication side effects.  His publications include over 240 research articles, reviews, chapters and edited volumes.  He serves as a member of the NICHD-sponsored Data Monitoring Board for the Best Pharmaceuticals for Children Act and as a member of the Institute of Medicine&;s Committee on Review of Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act.  He is the principle investigator of an NIMH-sponsored, multisite study of interventions for children who have gained weight on antipsychotic medication, and the site-PI of a 6-year follow-up study of preschoolers who were treated with medication for ADHD.  He was the Director of the Division of Child and Adolescent Psychiatry at Johns Hopkins from 1993-2009 and was the founding chair of the Interventions Review Committee for Disorders Involving Children and Their Families at the National Institute of Mental Health.